NCT06909474 2025-04-03Clinical Trial of CD5-targeted CAR-NK Therapy for Relapse/Refractory T-Cell Hematologic MalignanciesChongqing Precision Biotech Co., LtdPhase 1 Recruiting15 enrolled
NCT04014374 2024-07-24Post-authorization Safety Study of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Treated With MogamulizumabKyowa Kirin Co., Ltd.Recruiting150 enrolled